JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is a randomized, open‐label, controlled, phase III study to evaluate theefficacy and safety of JSKN033 versus investigator's choice of chemotherapy in patientswith recurrent or metastatic cervical cancer who have failed platinum‐based chemotherapyand PD‐1/L1 inhibitor therapy.
Epistemonikos ID: 6fa535bb7cf82bea8bd4983dee9c33f0743e90a3
First added on: Sep 01, 2026